> Press releases 2026
THX Pharma (Theranexus) and Exeltis secure EMA approval of the paediatric investigation plan (PIP) for TX01, unlocking the PUMA registration pathway
09/06/2026 18:00
Download PDF File (<1Mo)
THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day
09/06/2026 08:00
Download PDF File (<1Mo)
THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
28/04/2026 19:00
Download PDF File (<1Mo)
THX Pharma announces the publication of its letter to shareholders
25/03/2026 18:30
Download PDF File (<1Mo)
THX Pharma reports its cash position as of December 31, 2025
19/02/2026 18:00
Download PDF File (<1Mo)
THX Pharma to host a webinar to discuss its strategic agreement with Biocodex
12/02/2026 18:00
(<1Mo)
THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases
10/02/2026 18:00
Download PDF File (<1Mo)
Theranexus announces its financial calendar for 2026
20/01/2026
(<1Mo)
THX Pharma announces the appointment of Julien Veys as Deputy Chief Executive Officer
07/01/2026 8:00
Download PDF File (<1 Mo)